Beroni Group (XNEC:BTG) Common Stock : A$34.06 Mil (As of Jun. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Beroni Group Common Stock?

Beroni Group's quarterly common stock stayed the same from Jun. 2022 (A$30.79 Mil) to Dec. 2022 (A$30.79 Mil) but then increased from Dec. 2022 (A$30.79 Mil) to Jun. 2023 (A$34.06 Mil).

Beroni Group's annual common stock increased from Dec. 2020 (A$26.97 Mil) to Dec. 2021 (A$30.77 Mil) and increased from Dec. 2021 (A$30.77 Mil) to Dec. 2022 (A$30.79 Mil).

Beroni Group Common Stock Historical Data

The historical data trend for Beroni Group's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beroni Group Common Stock Chart

Beroni Group Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Common Stock

Get a 7-Day Free Trial

20.91

24.22

26.97

30.77

30.79

Beroni Group Semi-Annual Data
	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Common Stock	Get a 7-Day Free Trial									26.97	30.77	30.79	30.79	34.06

Beroni Group Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Beroni Group (XNEC:BTG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Conglomerates » Beroni Group Ltd (XNEC:BTG) » Definitions » Common Stock

Comparable Companies

Traded in Other Exchanges

BNIGF:USA

Address

Zhong Bei High Technology Industrial Park, Level 10, Building 11, Xiqing District, Tianjin, CHN, 300380

Website

https://www.beronigroup.com

Beroni Group Ltd is an Australia based company engaged in the sale of smoking control product (NicoBloc), air purifier, healthcare products and supplements, cosmetics and stem-cell therapies. It has organized its business into four core business areas: cell therapies, developing new anticancer drugs, an e-commerce platform for pharmaceutical and healthcare products, and detection & diagnosis of infectious diseases. Its operating segment includes Nicobloc, Fogibloc air purifier, Olansi water filter, Health supplements, Cosmetic products, Viral diagnostic kits, and Technical advisory service. Geographically, it operates in China and Japan. The highest revenue is generated from the Nicobloc segment through the China region.